MEREO BIOPHARMA GROUP PLC (MREO) Free cash flow 2022–2025
MEREO BIOPHARMA GROUP PLC (MREO) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$31.0MFY2025 · since FY2022: -$48.8M → -$31.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$31.0M | +5.6% |
| FY2024 | -$32.8M | -55.4% |
| FY2023 | -$21.1M | +56.7% |
| FY2022 | -$48.8M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More MREO financial trends
MREO RevenueMREO Net incomeMREO Net marginMREO Gross profitMREO Gross marginMREO Operating incomeMREO Operating marginMREO Operating cash flowMREO Capital expendituresMREO Return on equityMREO Stock buybacksMREO Dividends paidMREO Total assetsMREO Total liabilitiesMREO Shareholders’ equityMREO overview →